Investors

Azenta is dedicated to enabling life sciences organizations around the world to bring impactful breakthroughs and therapies to market – faster.

Stock Quote
NASDAQ: AZTA
Change:
Volume:
Market Cap:
Recent News
Nov 23, 2022

Azenta, Inc. (Nasdaq: AZTA) today announced that it has entered into an accelerated share repurchase agreement ("ASR") with JP Morgan Chase Bank, N.A. (the "Dealer") to repurchase $500 million of...

Nov 21, 2022

Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the virtual 5th Annual Evercore ISI HealthCONx Conference on Tuesday, November 29, 2022, which includes a...

Nov 14, 2022

Delivered on Expected Q4'22 Revenue of $138 million Strong Double-Digit Organic Growth Excluding COVID for Q4 and Full Fiscal Year Plan to Repurchase at Least $1 Billion of Common Stock Over the...

All Releases

Featured Events
Tue, Nov 29, 2022
3:30pm EST
Wed, Nov 16, 2022
12:00pm - 1:00pm CST
Mon, Nov 14, 2022
4:30pm - 5:30pm EST

Q4 2022 Earnings Call Presentation

Dial in: 800-936-4761

LEARN MORE ABOUT
AZENTA LIFE SCIENCES
Contact Investor Relations

Sara Silverman
Head of Investor Relations
(978) 262-2635
ir@azenta.com

Sherry Dinsmore
Executive Assistant to CFO
(978) 262-4301
sherry.dinsmore@azenta.com

Transfer Agent:

Computershare
P.O. Box 43006                                   
Providence RI 02940-3006                   
Investor Center web address:
https://www-us.computershare.com/investor

SIGN UP FOR ALERTS AND NEVER MISS INVESTOR UPDATES!

Subscribe

©2022 Azenta, Inc. All rights reserved. | Privacy & Security Policy
Loading data...